Atlas Trials

Efficacy and Safety of Direct Anti HCV Drugs in the Treatment of SARS-COV-2 (COVID-19)

Clinical trial NCT04535869 · UNKNOWN

Trial details

NCT number
NCT04535869
Sponsor
Mansoura University
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
COVID-19
Start date
2020-12-28
Primary completion
2021-04-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.